Cervical Cancer
Parasitic infection may raise risk for cervical cancer, researchers say
VIENNA — Schistosoma haematobium can trigger cancer-related gene activity in the cervix, increasing the risk for cervical cancer, according to data presented at the ESCMID Global meeting.
Adding pembrolizumab to chemoradiotherapy improves outcomes in high-risk cervical cancer
The addition of pembrolizumab to chemoradiotherapy improved survival outcomes for women with high-risk, locally advanced cervical cancer, according to data presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Adding cisplatin to radiation fails to extend survival in intermediate-risk cervical cancer
The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, early-stage cervical cancer who underwent radical hysterectomy, according to randomized phase 3 study results.
AK104 with concurrent radiotherapy shows efficacy in locally advanced cervical cancer
The addition of AK104 to concurrent chemoradiotherapy improved survival outcomes for patients with locally advanced cervical cancer, according to data presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Analysis of telehealth’s impact shows ‘modestly lower’ use of certain low-value tests
Health care systems that adopted a higher volume of telehealth services less frequently used several low-value screening and diagnostic tests, according to results of a cohort study published in JAMA Internal Medicine.
Transportation insecurity greatly reduces adherence to breast cancer screening
Individuals with transportation insecurity appeared 41% less likely to undergo breast cancer screening than those without transportation difficulties, according to results of a cohort study.
Cervical precancer incidence falls 80% among women most likely to be vaccinated for HPV
From 2008 to 2022, the incidence of cervical precancers fell by 80% among screened women aged 20 to 24 years, supporting recommendations for HPV vaccination at ages 11 to 12 years, researchers wrote in Morbidity and Mortality Weekly Report.
Q&A: Navigating management of women with high-risk HPV but normal cytology
Fewer than half of women who tested positive for HPV with negative cytological findings returned for a surveillance co-test within 1 year as recommended, yet more than half of those who received testing had HPV persistence or progression.
Cancer burden increasing among younger women, report shows
Cancer incidence has continued to rise in the U.S. since the 1990s — particularly among women and younger adults, according to an American Cancer Society report.
HPV-based screening better prevents invasive cervical cancer vs. cytology
HPV-based screening was superior to cytology in preventing invasive cervical cancer in real-world settings in Sweden, according to a randomized trial published in Lancet Public Health.